Plaquenil

In the US, Plaquenil (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Malaria, Malaria Prevention, Rheumatoid Arthritis, Sjogren's Syndrome, Systemic Lupus Erythematosus and Undifferentiated Connective Tissue Disease.

US matches:

• Plaquenil


• Plaquenil Sulfate

UK matches:

• Plaquenil
• Plaquenil Tablets (SPC)

Ingredient matches for Plaquenil

Hydroxychloroquine

Hydroxychloroquine is reported as an ingredient of Plaquenil in the following countries:

• Tunisia

Hydroxychloroquine sulfate (a derivative of Hydroxychloroquine) is reported as an ingredient of Plaquenil in the following countries:

• Argentina


• Australia


• Belgium


• Canada


• Czech Republic


• Denmark


• Estonia


• France


• Georgia


• Ghana


• Hong Kong


• Iceland


• Ireland


• Israel


• Italy


• Kenya


• Latvia


• Lithuania


• Luxembourg


• Malaysia


• Malta


• Mexico


• Netherlands


• New Zealand


• Nigeria


• Norway


• Romania


• Singapore


• Slovakia


• Sweden


• Switzerland


• Taiwan


• Tanzania


• Thailand


• Uganda


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.